Structural and physical features that distinguish tumor-controlling from inactive cancer neoepitopes

Area of Science:

• Immunology
• Oncology
• Vaccinology

Background:

• Neoepitopes from single nucleotide polymorphism-driven amino acid substitutions are T cell targets in cancer.
• Developing cancer vaccines requires understanding rare, protective neoepitopes that control tumor growth.
• Challenges include neoepitope scarcity and verifying human tumor control.

Purpose of the Study:

• To compare structural and physical properties of neoepitopes with varying protective capacities.
• To investigate differences between neoepitopes and their wild-type counterparts, considering immune tolerance.
• To identify features associated with neoepitope protection and T cell receptor recognition.

Main Methods:

• Utilized mouse models to overcome challenges in studying neoepitopes.
• Compared structural and physical properties of protective versus inactive neoepitopes.
• Analyzed differences from self-peptides and wild-type counterparts.

Main Results:

• Identified multiple features linked to neoepitope-mediated protection.
• Characterized features describing neoepitope divergence from self.
• Found features associated with recognition by diverse T cell receptor repertoires.

Conclusions:

• Neoepitope structural analysis shows promise and limitations for predictive modeling.
• Incorporating identified features can improve neoepitope prediction pipelines for cancer vaccines.
• Understanding neoepitope properties is vital for advancing cancer immunotherapy.